Citation

Hieronymus F, Lisinski A, Näslund J, Eriksson E. Acta Neuropsyciatr. 2018; 30(5): 266-274.

Copyright

(Copyright © 2018, Cambridge University Press)

DOI

10.1017/neu.2018.15

PMID

unavailable

Abstract

Funded by the Danish state to provide guidance in health-related matters, the Copenhagen Trial Unit (CTU) at Rigshospitalet may cause considerable societal harm if allowing their analyses to be influenced by bias and prejudice rather than rigor and impartiality. This is why we found it worthwhile to comment on a report from the CTU in which the authors invoked analyses marred by numerous errors and methodological mistakes to claim that selective serotonin reuptake inhibitors (SSRIs) are harmful and ineffective. The CTU group has now produced a response to our comment which is on par with their original contribution in terms of bias, misconceptions and mistakes. Our conclusion is that the reputation of the CTU would be best served by the authors asking for retraction of their SSRI paper.

Language: en

Keywords

antidepressants; clinical trials; depression; serotonin; SSRI